title: [Intracranial mixed germ cell tumor].
abstract: Objective:To study intracranial mixed germ cell tumor diagnosis and reasonable treatment strategy.Methods:Clinical data of 17 patients with intracranial mixed germ cell tumor in Tsinghua university Yuquan hospital from October 2012 to October 2016 were retrospective analysed, including the characteristics of the general, the serum tumor markers of AFP, β-HCG, and CEA, imaging findings, pathological results, treatment methods and prognosis.Results:There were 10 cases of male, 7 cases of female. The average age was (11.1±5.2) years old. Nine cases were gross total resection of lesions and 8 cases were subtotal resection of lesions. Eight cases (47.1%) were without recurrence and had more than four courses of chemotherapy after surgery, of which, 7 cases belonged to the gross total resection, and 1 case belonged to the subtotal resection. Nine (52.9%) patients relapsed, including 2 cases of the gross total resection and 7 cases of the subtotal resection. Among them, 4 cases were given second operations and 6 cases obtained satisfactory therapeutic effect by chemotherapy combined radiotherapy. There were 12 of 17 patients with pathological types contain teratoma (including mature, immature or malignant teratoma) ingredients, accounting for 70.6%. The average follow-up time was (17.5±12.1) months, 4 cases (23.5%) patients died.Conclusion:The diagnosis of intracranial mixed germ cell tumors needs comprehensive consideration of tumor markers in serum or cerebrospinal fluid, chemotherapy and radiotherapy before operation and pathological results. The gross total resection helps to reduce the chances of tumor recurrence. Rational chemotherapy and radiotherapy is helpful to prognosis.
authors.affiliation: The Medical Center, Tsinghua University, Beijing 100084, China.
authors.forename: Y P
authors.initials: YP
authors.lastname: Zhao
authors.forename: Y Q
authors.initials: YQ
authors.lastname: Zhang
authors.forename: H Y
authors.initials: HY
authors.lastname: Duan
authors.forename: Y
authors.initials: Y
authors.lastname: Ma
authors.forename: H
authors.initials: H
authors.lastname: Liang
authors.forename: Q H
authors.initials: QH
authors.lastname: Zhang
authors.forename: C Q
authors.initials: CQ
authors.lastname: Xue
authors.forename: B
authors.initials: B
authors.lastname: Luo
authors.forename: X
authors.initials: X
authors.lastname: Pan
mesh_terms: D000293:Adolescent; D014408:Biomarkers, Tumor; D002648:Child; D002675:Child, Preschool; D018997:Chorionic Gonadotropin, beta Subunit, Human; D005260:Female; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local; D009373:Neoplasms, Germ Cell and Embryonal; D011379:Prognosis; D012189:Retrospective Studies; D013724:Teratoma
chemical_list: D014408:Biomarkers, Tumor; D018997:Chorionic Gonadotropin, beta Subunit, Human
keywords: Chemotherapy; Mixed germ cell tumors; Radiation therapy; Surgery; Tumor markers